Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126325271 | 12632527 | 1 | I | 20160622 | 20160708 | 20160808 | 20160808 | EXP | US-SHIRE-US201608439 | SHIRE | 61.94 | YR | F | Y | 52.10000 | KG | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126325271 | 12632527 | 1 | PS | GATTEX | TEDUGLUTIDEWATER | 1 | Subcutaneous | 0.05 MG/KG, 1X/DAY:QD | 203441 | .05 | MG/KG | SOLUTION FOR INJECTION | QD | ||||||
| 126325271 | 12632527 | 2 | SS | DYAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Unknown | 37.5 MG, UNKNOWN | 0 | 37.5 | MG | ||||||||
| 126325271 | 12632527 | 3 | C | TPN | AMINO ACIDSDEXTROSEELECTROLYTES NOSSOYBEAN OIL | 1 | Unknown | UNK, OTHER (2 DAYS A WEEK) | 0 | ||||||||||
| 126325271 | 12632527 | 4 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 4000 IU, 1X/DAY:QD | 0 | 4000 | IU | QD | |||||||
| 126325271 | 12632527 | 5 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | UNK, UNKNOWN | 0 | ||||||||||
| 126325271 | 12632527 | 6 | C | RANITIDINE. | RANITIDINE | 1 | Oral | UNK, 2X/DAY:BID | 0 | TABLET | BID | ||||||||
| 126325271 | 12632527 | 7 | C | ACETAMINOPHEN AND CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126325271 | 12632527 | 8 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0.5 MG, AS REQ'D9EVERY 4 TO 6 HOURS) | 0 | .5 | MG | TABLET | |||||||
| 126325271 | 12632527 | 9 | C | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | (11MCG-25MCG/DOSE), 1X/DAY:QD | 0 | QD | ||||||||||
| 126325271 | 12632527 | 10 | C | BUPROPION HCL ER | BUPROPION HYDROCHLORIDE | 1 | Unknown | 300 MG, 1X/DAY:QD | 0 | 300 | MG | QD | |||||||
| 126325271 | 12632527 | 11 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 500 MG, UNKNOWN | 0 | 500 | MG | TABLET | |||||||
| 126325271 | 12632527 | 12 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126325271 | 12632527 | 13 | C | DEPLIN | LEVOMEFOLATE CALCIUM | 1 | Unknown | UNK, 1X/DAY:QD | 0 | CAPSULE | QD | ||||||||
| 126325271 | 12632527 | 14 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | 100 MG, UNKNOWN | 0 | 100 | MG | CAPSULE | |||||||
| 126325271 | 12632527 | 15 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 1 MG, UNKNOWN | 0 | 1 | MG | TABLET | |||||||
| 126325271 | 12632527 | 16 | C | HYDROXYZINE HCL | HYDROXYZINE HYDROCHLORIDE | 1 | Unknown | 25 MG, UNKNOWN | 0 | 25 | MG | TABLET | |||||||
| 126325271 | 12632527 | 17 | C | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | (0.005%)UNKNOWN | 0 | ||||||||||
| 126325271 | 12632527 | 18 | C | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | 2 MG, UNKNOWN | 0 | 2 | MG | CAPSULE | |||||||
| 126325271 | 12632527 | 19 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | 10 MG, UNKNOWN | 0 | 10 | MG | TABLET | |||||||
| 126325271 | 12632527 | 20 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | 25 MG, UNKNOWN | 0 | 25 | MG | TABLET | |||||||
| 126325271 | 12632527 | 21 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | 250 MG, UNKNOWN | 0 | 250 | MG | TABLET | |||||||
| 126325271 | 12632527 | 22 | C | NITROFURANTOIN MONOHYDRATE MACROCRYSTALS | NITROFURANTOINNITROFURANTOIN MONOHYDRATE | 1 | Unknown | 100 MG, UNKNOWN | 0 | 100 | MG | CAPSULE | |||||||
| 126325271 | 12632527 | 23 | C | ONDANSETRON HCL | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | 4 MG, UNKNOWN | 0 | 4 | MG | TABLET | |||||||
| 126325271 | 12632527 | 24 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | 50 MG, 1X/DAY:QD | 0 | 50 | MG | TABLET | QD | ||||||
| 126325271 | 12632527 | 25 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Unknown | 5,000 UNIT CAPSULE, UNKNOWN | 0 | CAPSULE | |||||||||
| 126325271 | 12632527 | 26 | C | ZOSTAVAX | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1 | Unknown | (19,400UNIT/0.65 ML), UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126325271 | 12632527 | 1 | Short-bowel syndrome |
| 126325271 | 12632527 | 2 | Product used for unknown indication |
| 126325271 | 12632527 | 3 | Product used for unknown indication |
| 126325271 | 12632527 | 4 | Vitamin D deficiency |
| 126325271 | 12632527 | 6 | Product used for unknown indication |
| 126325271 | 12632527 | 7 | Product used for unknown indication |
| 126325271 | 12632527 | 8 | Product used for unknown indication |
| 126325271 | 12632527 | 9 | Product used for unknown indication |
| 126325271 | 12632527 | 10 | Product used for unknown indication |
| 126325271 | 12632527 | 11 | Product used for unknown indication |
| 126325271 | 12632527 | 12 | Product used for unknown indication |
| 126325271 | 12632527 | 13 | Product used for unknown indication |
| 126325271 | 12632527 | 14 | Product used for unknown indication |
| 126325271 | 12632527 | 15 | Product used for unknown indication |
| 126325271 | 12632527 | 16 | Product used for unknown indication |
| 126325271 | 12632527 | 17 | Product used for unknown indication |
| 126325271 | 12632527 | 18 | Product used for unknown indication |
| 126325271 | 12632527 | 19 | Product used for unknown indication |
| 126325271 | 12632527 | 20 | Product used for unknown indication |
| 126325271 | 12632527 | 21 | Product used for unknown indication |
| 126325271 | 12632527 | 22 | Product used for unknown indication |
| 126325271 | 12632527 | 23 | Product used for unknown indication |
| 126325271 | 12632527 | 24 | Product used for unknown indication |
| 126325271 | 12632527 | 25 | Product used for unknown indication |
| 126325271 | 12632527 | 26 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126325271 | 12632527 | DE |
| 126325271 | 12632527 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126325271 | 12632527 | Cardiac arrest | |
| 126325271 | 12632527 | Hypoalbuminaemia | |
| 126325271 | 12632527 | Malnutrition | |
| 126325271 | 12632527 | Oedema peripheral | |
| 126325271 | 12632527 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126325271 | 12632527 | 1 | 20151110 | 0 | ||
| 126325271 | 12632527 | 2 | 20160707 | 0 | ||
| 126325271 | 12632527 | 3 | 201402 | 0 | ||
| 126325271 | 12632527 | 4 | 20160707 | 0 | ||
| 126325271 | 12632527 | 6 | 20160707 | 0 | ||
| 126325271 | 12632527 | 7 | 20160217 | 0 | ||
| 126325271 | 12632527 | 9 | 20160607 | 0 | ||
| 126325271 | 12632527 | 10 | 20160702 | 0 | ||
| 126325271 | 12632527 | 11 | 20160629 | 0 | ||
| 126325271 | 12632527 | 12 | 20160520 | 0 | ||
| 126325271 | 12632527 | 13 | 20160203 | 0 | ||
| 126325271 | 12632527 | 14 | 20160411 | 0 | ||
| 126325271 | 12632527 | 15 | 20160419 | 0 | ||
| 126325271 | 12632527 | 16 | 20160525 | 0 | ||
| 126325271 | 12632527 | 17 | 20160702 | 0 | ||
| 126325271 | 12632527 | 18 | 20160429 | 0 | ||
| 126325271 | 12632527 | 19 | 20160411 | 0 | ||
| 126325271 | 12632527 | 20 | 20160702 | 0 | ||
| 126325271 | 12632527 | 21 | 20160318 | 0 | ||
| 126325271 | 12632527 | 22 | 20150819 | 0 | ||
| 126325271 | 12632527 | 23 | 20150819 | 0 | ||
| 126325271 | 12632527 | 24 | 20160702 | 0 | ||
| 126325271 | 12632527 | 25 | 20160603 | 0 | ||
| 126325271 | 12632527 | 26 | 20151231 | 0 |